Novartis agreed to acquire Bannockburn-based AveXis to gain a promising drug to treat a rare disease that afflicts infants.
from nicholemhearn digest http://www.chicagobusiness.com/article/20180409/NEWS03/180409912/local-gene-therapy-firm-to-sell-for-almost-9-billion?utm_source=NEWS03&utm_medium=rss&utm_campaign=chicagobusiness
No comments:
Post a Comment